[Postoperative Viscum album therapy after surgery of breast neoplasms]

From a selection of 547 patients with mamma carcinoma stages I and II it is statistically shown that the 5- and 10-year survival rates are significantly improved with postoperative use of Iscador (Viscum album); this in comparison with the conventional treatment on its own. No toxic side effects have been experienced.